REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

BIOGEN HUNGARY Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: BIOGEN HUNGARY Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Biogen Hungary Kft. is the Hungarian subsidiary of Biogen Inc. Business segments include research, development and marketing of therapies for neurological and neurodegenerative diseases. Geographic scope is Hungary. Key assets include proprietary pharmaceutical products. Strategic focus is on innovative biopharmaceutical therapies.

Headquarters
Dorottya Udvar Bocskai ut 134-146. E. ep. 2. emelet
Budapest; Budapest; Postal Code: 1113

Contact Details: Purchase the BIOGEN HUNGARY Kft. report to view the information.

Website: http://www.biogenidec.hu

Basic Information
Total Employees:
Purchase the BIOGEN HUNGARY Kft. report to view the information.
Registered Capital:
Purchase the BIOGEN HUNGARY Kft. report to view the information.
Financial Auditors:
Purchase the BIOGEN HUNGARY Kft. report to view the information.
Incorporation Date:
October 14, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after BIOGEN HUNGARY Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-25.27%▼
Total operating revenue
-24.75%▼
Operating Profit/Loss (EBIT)
3.33%▲
EBITDA
3.38%▲
Net Profit/Loss for the Period
0.89%▲
Total Assets
-2.05%▼
Total Equity
9.36%▲
Operating Profit Margin (ROS)
1.13%▲
Net Profit Margin
0.95%▲
Return on Equity (ROE)
-0.72%▼
Quick Ratio
1.48%▲
Cash Ratio
1.86%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo